Reckitt Benckiser Group Plc’s (RB) Buy Rating Reaffirmed at Whitman Howard

Reckitt Benckiser Group Plc (LON:RB)‘s stock had its “buy” rating reiterated by investment analysts at Whitman Howard in a research note issued to investors on Monday. They currently have a GBX 9,000 ($118.33) price target on the stock. Whitman Howard’s price objective indicates a potential upside of 25.23% from the company’s previous close.

RB has been the subject of a number of other reports. J P Morgan Chase & Co boosted their price objective on shares of Reckitt Benckiser Group Plc from GBX 7,250 ($95.32) to GBX 7,300 ($95.98) and gave the stock a “neutral” rating in a report on Tuesday, June 20th. Goldman Sachs Group, Inc. (The) decreased their price objective on shares of Reckitt Benckiser Group Plc from GBX 8,130 ($106.89) to GBX 7,920 ($104.13) and set a “neutral” rating for the company in a report on Thursday, September 21st. Societe Generale set a GBX 7,800 ($102.55) price objective on shares of Reckitt Benckiser Group Plc and gave the stock a “neutral” rating in a report on Tuesday, September 5th. Jefferies Group LLC decreased their price objective on shares of Reckitt Benckiser Group Plc from GBX 8,200 ($107.81) to GBX 8,150 ($107.15) and set a “hold” rating for the company in a report on Tuesday, July 25th. Finally, Kepler Capital Markets set a GBX 7,800 ($102.55) price objective on shares of Reckitt Benckiser Group Plc and gave the stock a “neutral” rating in a report on Wednesday, July 26th. Two equities research analysts have rated the stock with a sell rating, fourteen have issued a hold rating and eight have given a buy rating to the company. The stock presently has an average rating of “Hold” and an average target price of GBX 7,950.87 ($104.53).

Shares of Reckitt Benckiser Group Plc (LON:RB) opened at 7093.00 on Monday. The company’s market capitalization is GBX 49.90 billion. The firm’s 50-day moving average price is GBX 6,992.71 and its 200-day moving average price is GBX 7,418.69. Reckitt Benckiser Group Plc has a one year low of GBX 6,496.00 and a one year high of GBX 8,110.43.

TRADEMARK VIOLATION NOTICE: This piece of content was published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece of content on another site, it was stolen and reposted in violation of U.S. & international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://www.dispatchtribunal.com/2017/10/16/reckitt-benckiser-group-plcs-rb-buy-rating-reaffirmed-at-whitman-howard.html.

Reckitt Benckiser Group Plc Company Profile

Reckitt Benckiser Group plc is a manufacturer and marketer of health, hygiene and home products. The Company’s segments include ENA and DvM. The ENA segment consists of Europe, Russia/Commonwealth of Independent States (CIS), Israel, North America, Australia and New Zealand. The DvM segment consists of North Africa, Middle East (excluding Israel) and Turkey, Africa, South Asia, North Asia, Latin America, Japan, Korea and the Association of Southeast Asian Nations (ASEAN).

Analyst Recommendations for Reckitt Benckiser Group Plc (LON:RB)

Receive News & Ratings for Reckitt Benckiser Group Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group Plc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply